Callos Andrew sold CYTK
March 2, 2026 · Form 4 insider transaction
Callos Andrew sold 886 shares of Cytokinetics, Incorporated at $61.62 per share, a transaction worth $54.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
886
Price
$61.62
Total value
$54.6K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 2, 2026
Shares owned after50,440
OwnershipDirect
10b5-1 planNo
AmendedNo